Table 1.
Characteristic | United States (OPTN/SRTR), 2016–2018, N=2235 | Europe (ESPN/ERA-EDTA), 1990–2012, N=3718 | Australia and New Zealand (ANZDATA), 1994–2013, N=750 | United Kingdom (NHS/UKTR), 1992–2016, N=3236 |
---|---|---|---|---|
Recipient age, yr | ||||
0–5 | 510 (23) | 983 (26) | 177 (24) | 640 (20) |
6–10 | 427 (19) | 1540 (41) | 157 (21) | 918 (28) |
11–17 | 1298 (58) | 1195 (32) | 416 (55) | 1678 (52) |
Male | 1310 (59) | 2109 (60) | 437 (58) | 1955 (60) |
Race | ||||
White | 1079 (48) | a | 597 (80) | 2354 (73) |
Black | 389 (17) | a | a | 86 (3) |
Asian | 102 (5) | a | a | 447 (14) |
Other | 58 (3) | a | 153 (20) | 349 (11) |
Living donor | 759 (34) | 1098 (30) | 497 (66) | 1155 (36) |
Preemptive | 648 (29) | 29% | 172 (23) | 641 (20) |
Kidney diagnosis | ||||
CAKUT | 771 (34) | 1594 (46) | 330 (44) | 525 (16) Renal dysplasia |
GN | 192 (9) | 463 (13) | 231 (31) | 315 (10) |
FSGS | 271 (12) | a | a | a |
Other | 1001 (45) | 1661 (45) | 189 (25) | 2396 (74) |
Allograft survival | ||||
Deceased donor | ||||
5-yr | 83% | 90% | 81% | 75% |
10-yr | 61% | 77% | 62% | 61% |
Living donor | ||||
5-yr | 91% | 85% | 90% | 89% |
10-yr | 70% | 72% | 75% | 74% |
Patient survival | ||||
Deceased donor | ||||
5-yr | 98% | a | 90% | 96% |
10-yr | a | a | 75% | 92% |
Living donor | ||||
5-yr | 98% | a | 95% | 98% |
10-yr | a | a | 88% | 94% |
Data are shown as n (%). Data obtained from OPTN/SRTR, ESPN/ERA-EDTA, ANZDATA, and NHS/UKTR. OPTN/SRTR, Organ Procurement and Transplant Network/Scientific Registry of Transplant Recipients; ESPN/ERA-EDTA, European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association; ANZDATA, Australia and New Zealand Dialysis and Transplant; NHS/UKTR, National Health Service/UK Transplant Registry; CAKUT, congenital anomalies of the kidneys and urinary tract.
Not reported.